Aficamten, Tablet placebo for aficamten 5mg tablet
CY 6023
Phase 3 small_molecule active
Quick answer
Aficamten, Tablet placebo for aficamten 5mg tablet for SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY is a Phase 3 program (small_molecule) at Cytokinetics (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cytokinetics (Ireland) Limited
- Indication
- SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active